Cargando…
Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling
BACKGROUND: We applied a non-linear immunokinetic model to quantitatively compare absolute antibody uptake and turnover in subcutaneous LNCaP human prostate cancer (PCa) xenografts of two radiolabeled forms of the humanized anti-prostate-specific membrane antigen (PSMA) monoclonal antibody J591 ((12...
Autores principales: | Fung, Edward K., Cheal, Sarah M., Fareedy, Shoaib B., Punzalan, Blesida, Beylergil, Volkan, Amir, Jawaria, Chalasani, Sandhya, Weber, Wolfgang A., Spratt, Daniel E., Veach, Darren R., Bander, Neil H., Larson, Steven M., Zanzonico, Pat B., Osborne, Joseph R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723373/ https://www.ncbi.nlm.nih.gov/pubmed/26801327 http://dx.doi.org/10.1186/s13550-016-0164-0 |
Ejemplares similares
-
Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors
por: Pandit-Taskar, Neeta, et al.
Publicado: (2015) -
Radiolabeled PSMA Inhibitors
por: Neels, Oliver C., et al.
Publicado: (2021) -
Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma
por: Cheal, Sarah M., et al.
Publicado: (2018) -
PSMA as a target for radiolabelled small molecules
por: Eder, Matthias, et al.
Publicado: (2013) -
Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate Cancer
por: Tagawa, Scott T., et al.
Publicado: (2013)